| Dr Richard Carroll Moore Jr, MD | |
|
1849 W Plaza Dr, Suite 200, Winchester, VA 22601-6365 | |
| (540) 450-0233 | |
| (540) 450-0235 |
| Full Name | Dr Richard Carroll Moore Jr |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1849 W Plaza Dr, Winchester, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407060346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Carroll Moore Jr, MD 1849 W Plaza Dr, Suite 200, Winchester, VA 22601-6365 Ph: (540) 450-0233 | Dr Richard Carroll Moore Jr, MD 1849 W Plaza Dr, Suite 200, Winchester, VA 22601-6365 Ph: (540) 450-0233 |
News Archive
Researchers have found that nafamostat mesylate, when injected in the nasal cavity of Syrian hamsters, can decrease initial SARS-CoV-2 viral loads in their nose. However, this effect was temporary and further testing is required to determine clinically significant effects. The research group's findings are available on the preprint server bioRxiv*.
The U.S. Food and Drug Administration today approved B. Braun Medical Inc.'s application for 1g and 2g Ceftazidime for Injection USP and Dextrose Injection USP in the DUPLEX Drug Delivery System.
Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.
Deprivation represents the "elephant in the room" with regard to cardiovascular disease, and health care professionals have an important role to play in tackling the problem, delegates heard at a special plenary session opening the EuroHeart Care Congress in Glasgow, Scotland, 22 March to 23 March 2013.
As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model.
› Verified 8 days ago
Barbara Anne Harris Feshami, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 170 Prosperity Dr, Winchester, VA 22602 Phone: 540-869-0600 | |
Katelyn Nicewander, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 | |
Mrs. Angela Lynn Titus, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 172 Linden Dr Ste 107, Winchester, VA 22601 Phone: 540-678-0767 Fax: 540-678-0769 | |
Dr. Arthur Sterling Ticknor, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Merchant St Ste 100, Winchester, VA 22603 Phone: 540-536-5560 Fax: 540-536-5561 | |
Brendan Michael Flynn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 W Cork St Unit 405, Winchester, VA 22601 Phone: 540-313-9200 | |
Dr. Sean Sutphen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 Fax: 540-536-2206 | |
Sam Waltos, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 104 Selma Dr, Winchester, VA 22601 Phone: 540-678-2800 Fax: 540-667-0652 |